Literature DB >> 28429238

The growing role of biology in the treatment of glioblastoma: no more one kind of disease.

Michela Buglione1, Luca Triggiani2, Stefano Maria Magrini2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28429238     DOI： 10.1007/s11060-017-2417-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

1.  Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?

Authors:  Michela Buglione; Sara Pedretti; Pietro Luigi Poliani; Roberto Liserre; Stefano Gipponi; Giannantonio Spena; Paolo Borghetti; Ludovica Pegurri; Federica Saiani; Luigi Spiazzi; Giulia Tesini; Chiara Uccelli; Luca Triggiani; Stefano Maria Magrini
Journal:  J Neurooncol       Date:  2016-03-30       Impact factor: 4.130

2.  EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.

Authors:  Manuela Cominelli; Salvatore Grisanti; Stefania Mazzoleni; Caterina Branca; Luciano Buttolo; Daniela Furlan; Barbara Liserre; Maria Fausta Bonetti; Daniela Medicina; Vilma Pellegrini; Michela Buglione; Roberto Liserre; Serena Pellegatta; Gaetano Finocchiaro; Piero Dalerba; Fabio Facchetti; Marina Pizzi; Rossella Galli; Pietro Luigi Poliani
Journal:  J Natl Cancer Inst       Date:  2015-03-03       Impact factor: 13.506

3.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

4.  The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma.

Authors:  Paolo Tini; Pierpaolo Pastina; Valerio Nardone; Lucio Sebaste; Marzia Toscano; Clelia Miracco; Alfonso Cerase; Luigi Pirtoli
Journal:  Clin Neurol Neurosurg       Date:  2016-07-18       Impact factor: 1.876
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.